Evaluation of qCON and qNOX indices for neuromonitoring during general anaesthesia
Not Applicable
Completed
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/03/032092
- Lead Sponsor
- Army Hospital Research and Referral
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 46
Inclusion Criteria
1.ASA Grade I and II
2.Patients between 1 to 12 years of age,
3.Patients of both sexes
4.Procedures under General Anaesthesia using volatile anaesthetics (sevoflurane)
5.Patientââ?¬•s NOK giving valid informed consent
Exclusion Criteria
1.Patientââ?¬•s NOK Refusal
2.Any cardiac disease (NYHA III and IV) and/or severe liver dysfunction.
3.Any neurological disease or child diagnosed with any syndrome.
4.Emergency cases.
5.Difficult anticipated airway.
6.Patient in severe sepsis or shock.
7.Any dermatological conditions involving the forehead
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the qCON and qNOX indices for depth of anaesthesia and response of patient to noxious stimulus respectively in paediatric population.Timepoint: Post laryngoscopes and intubation and post skin incision.
- Secondary Outcome Measures
Name Time Method To study the correlation between <br/ ><br>1.The qCON index with the consciousness level and minimum alveolar concentration (MAC) of anaesthetic drug to track changes in the effects of anaesthetics in the brain. <br/ ><br>2.The qNOX index with response of patient to noxious stimulus such as tracheal intubation using endotracheal tube or supraglottic airway insertion and surgical incision. <br/ ><br>Timepoint: Post laryngoscopes and intubation and post skin incision.